Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIV(mac251) Acquisition

Guardado en:
Detalles Bibliográficos
Publicado en:AIDS Res Hum Retroviruses
Autores principales: Vaccari, Monica, Gordon, Shari N., Fourati, Slim, Schifanella, Luca, Cameron, Mark, Keele, Brandon F., Shen, Xiaoying, Tomaras, Georgia, Billings, Erik, Rao, Mangala, Liyanage, Namal P.M., Vargas-Inchaustegui, Diego A., Whitney, Steve, Doster, Melvin N., Binello, Nicolo, Pegu, Poonam, Montefiori, David C., Foulds, Kathryn, Quinn, David S., Donaldson, Mitzi, Liang, Frank, Lore, Karin, Roederer, Mario, Koup, Richard, McDermott, Adrian, Ma, Zhong-Min, Christopher, Miller, Phan, Tran B., Forthal, Donald N., Blackburn, Matthew, Caccuri, Francesca, Ferrari, Guido, Robert-Guroff, Marjorie, Ratto-Kim, Silvia, Kim, Jerome, Michael, Nelson, Phogat, Sanjay, Barnett, Susan W., Tartaglia, James, Venzon, David, Stablein, Donald M., Sekaly, Rafick-Pierre, Franchini, Genoveffa
Formato: Artigo
Lenguaje:Inglês
Publicado: Mary Ann Liebert, Inc. 2014
Materias:
Adjuvants and Immunogens
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4228741/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2014.5117.abstract
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares